메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 35, Issue 14, 2017, Pages 1623-
Neoadjuvant therapy in resectable pancreatic cancer: Immortal time bias and its correction
Author keywords

[No Author keywords available]
Indexed keywords

CANCER ADJUVANT THERAPY; CANCER SURGERY; CANCER SURVIVAL; HUMAN; LETTER; NEOADJUVANT THERAPY; OVERALL SURVIVAL; PANCREAS CANCER; PRIORITY JOURNAL; PANCREAS TUMOR; PROPENSITY SCORE; STATISTICAL BIAS;
EID: 85019081879     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2016.71.2273     Document Type: Letter
Times cited : (13)
References (8)
  • 1
    • 84880573171 scopus 로고    scopus 로고
    • A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer
    • Kim EJ, Ben-Josef E, Herman JM, et al: A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer. Cancer 119:2692-2700, 2013
    • (2013) Cancer , vol.119 , pp. 2692-2700
    • Kim, E.J.1    Ben-Josef, E.2    Herman, J.M.3
  • 2
    • 85012863530 scopus 로고    scopus 로고
    • Neoadjuvant therapy followed by resection versus upfront resection for resectable pancreatic cancer: A propensity score matched analysis
    • epub ahead of print on September 12
    • Mokdad AA, Minter RM, Zhu H, et al: Neoadjuvant therapy followed by resection versus upfront resection for resectable pancreatic cancer: A propensity score matched analysis. J Clin Oncol 10.1200/JCO.2016.68.5081[epub ahead of print on September 12, 2016]
    • (2016) J Clin Oncol
    • Mokdad, A.A.1    Minter, R.M.2    Zhu, H.3
  • 4
    • 77951579430 scopus 로고    scopus 로고
    • Problem of immortal time bias in cohort studies: Example using statins for preventing progression of diabetes
    • Lévesque LE, Hanley JA, Kezouh A, et al: Problem of immortal time bias in cohort studies: Example using statins for preventing progression of diabetes. BMJ 340:b5087, 2010
    • (2010) BMJ , vol.340 , pp. b5087
    • Lévesque, L.E.1    Hanley, J.A.2    Kezouh, A.3
  • 5
    • 39349101029 scopus 로고    scopus 로고
    • Immortal time bias in pharmaco-epidemiology
    • Suissa S: Immortal time bias in pharmaco-epidemiology. Am J Epidemiol 167:492-499, 2008
    • (2008) Am J Epidemiol , vol.167 , pp. 492-499
    • Suissa, S.1
  • 6
    • 44049108508 scopus 로고    scopus 로고
    • The secret of immortal time bias in epidemiologic studies
    • Shariff SZ, Cuerden MS, Jain AK, et al: The secret of immortal time bias in epidemiologic studies. J Am Soc Nephrol 19:841-843, 2008
    • (2008) J Am Soc Nephrol , vol.19 , pp. 841-843
    • Shariff, S.Z.1    Cuerden, M.S.2    Jain, A.K.3
  • 7
    • 4444283796 scopus 로고    scopus 로고
    • Time-dependent bias was common in survival analyses published in leading clinical journals
    • van Walraven C, Davis D, Forster AJ, et al: Time-dependent bias was common in survival analyses published in leading clinical journals. J Clin Epidemiol 57:672-682, 2004
    • (2004) J Clin Epidemiol , vol.57 , pp. 672-682
    • Van Walraven, C.1    Davis, D.2    Forster, A.J.3
  • 8
    • 84951569622 scopus 로고    scopus 로고
    • Understanding and avoiding immortal-time bias in gastrointestinal observational research
    • Targownik LE, Suissa S: Understanding and avoiding immortal-time bias in gastrointestinal observational research. Am J Gastroenterol 110:1647-1650, 2015
    • (2015) Am J Gastroenterol , vol.110 , pp. 1647-1650
    • Targownik, L.E.1    Suissa, S.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.